首页 | 本学科首页   官方微博 | 高级检索  
     

黄连解毒汤中小檗碱及其他成分模拟组合在脑缺血大鼠体内药动学比较研究
引用本文:王文哲,周 静,郭立玮,朱华旭,潘林梅,潘永兰. 黄连解毒汤中小檗碱及其他成分模拟组合在脑缺血大鼠体内药动学比较研究[J]. 中草药, 2014, 45(1): 64-68
作者姓名:王文哲  周 静  郭立玮  朱华旭  潘林梅  潘永兰
作者单位:南京中医药大学药学院 中药复方分离工程重点实验室,江苏 南京 210029
基金项目:江苏省自然科学基金资助项目(BK2012855);江苏省中医药管理局资助项目(LZ11199);江苏省高校优势学科项目;南京中医药大学中医学优势学科开放课题(S2012ZYX310)
摘    要:目的 比较基于黄连解毒汤原方比例的4种不同模拟组合中主成分小檗碱在脑缺血模型大鼠体内的药动学变化过程。方法 大鼠按体质量分为模型组和假手术组,模型组以线栓法复制大鼠脑缺血模型。每组又分为4个亚组,分别为小檗碱(247.4 mg/kg)组、小檗碱(247.4 mg/kg)+黄芩苷(190.7 mg/kg)组、小檗碱(247.4 mg/kg)+栀子苷(149.5 mg/kg)组、小檗碱(247.4 mg/kg)+栀子苷(149.5 mg/kg)+黄芩苷(190.7 mg/kg)组。各组分别于ig给药后0.083、0.25、0.5、1、2、3、4、6、8、10、12、24、48、72 h 眼眶取血,HPLC法测定小檗碱在大鼠血浆中的浓度变化,绘制药-时曲线,DAS 2.0计算药动学参数。结果 根据统计矩参数,模型组和假手术组小檗碱的吸收顺序均为小檗碱+栀子苷组>小檗碱+栀子苷+黄芩苷组>小檗碱组>小檗碱+黄芩苷组。结论 针对脑缺血模型,黄连解毒汤中的栀子苷可促进小檗碱的吸收,黄芩苷则对小檗碱的吸收有一定的抑制作用,而三者组合给药后栀子苷可以降低黄芩苷对小檗碱吸收的抑制作用。

关 键 词:黄连解毒汤;小檗碱;脑缺血;模拟组合;药动学

Comparative study on in vivo pharmacokinetics of simulated combination of berberine and other ingredients in Huanglian Jiedu Decoction in rats with cerebral ischemia
WANG Wen-zhe,ZHOU Jing,GUO Li-wei,ZHU Hua-xu,PAN Lin-mei,PAN Yong-lan. Comparative study on in vivo pharmacokinetics of simulated combination of berberine and other ingredients in Huanglian Jiedu Decoction in rats with cerebral ischemia[J]. Chinese Traditional and Herbal Drugs, 2014, 45(1): 64-68
Authors:WANG Wen-zhe  ZHOU Jing  GUO Li-wei  ZHU Hua-xu  PAN Lin-mei  PAN Yong-lan
Affiliation:Key Laboratory of Separation Engineering of Chinese Materia Medica Compound, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210029, China
Abstract:Objective To compare the pharmacokinetic changing process of the main component berberine in four different simulated combinations based on the proportion of Huanglian Jiedu Decoction (HJD) in rats with cerebral ischemia. Methods According to body weight the rats were divided into model and Sham groups, and the middle cerebral artery occlusion (MCAO) was reproduced by suture method to make rats with cerebral ischemia in the model group. Each group was divided into four sub-groups: berberine (247.4 mg/kg), berberine (247.4 mg/kg) + baicalin (190.7 mg/kg), berberine (247.4 mg/kg) + geniposide (149.5 mg/kg), and berberine (247.4 mg/kg) + geniposide (149.5 mg/kg) + baicalin (190.7 mg/kg) groups. After ig administration, orbital blood was collected in 0.083, 0.25, 0.5, 1, 2, 3, 4, 6, 8, 10, 12, 24, 48, and 72 h, respectively. HPLC method was used for the determination of berberine concentration change in rat plasma. The concentration-time curve was plotted and the pharmacokinetic parameters were calculated by DAS 2.0. Results According to the statistical parameters, the absorbed order of berberine in the model and Sham groups was as follows: berberine + geniposide > berberine + geniposide + baicalin > berberine > berberine + baicalin. Conclusion For MCAO rats, geniposide in HJD could promote the absorption of berberine, and baicalin could inhibit the absorption of berberine, but the combination of the three could alleviate the inhibition of berberine absorption by baicalin.
Keywords:Huanglian Jiedu Decoction   berberine   cerebral ischemia   simulated combination   pharmacokinetics
本文献已被 CNKI 等数据库收录!
点击此处可从《中草药》浏览原始摘要信息
点击此处可从《中草药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号